How should I submit Medicare claims for Radium Ra-223?

Radium Ra-223 is FDA approved for the treatment of individuals with castration-resistant prostate cancer. For dates of service beginning January 1, 2015, hospital outpatient departments should bill Medicare for Radium Ra-223, using HCPCS code A9606. The revenue code 0636 should also appear on the claim.  In addition to needing the dosage noted on the claim, the provider also needs to indicate that bone metastases are present and that visceral metastases are absent in the Remarks field on the UB-04 or its electronic equivalent.


Contact Palmetto GBA JM Part A Medicare

Provider Contact Center: 855-696-0705

Email Part A

Contact a specific JM Part A department

Other Palmetto GBA Sites

Palmetto GBA Home

DMEPOS Competitive Bidding Program

Jurisdiction J Part A MAC

Jurisdiction J Part B MAC

Jurisdiction M Part A MAC

Jurisdiction M Part B MAC

Jurisdiction M Home Health and Hospice MAC


National Supplier Clearinghouse MAC


RRB Specialty MAC Providers

RRB Specialty MAC Beneficiaries



Click to Chat Now